JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M105189200 on July 20, 2001

J. Biol. Chem., Vol. 276, Issue 38, 35564-35570, September 21, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/38/35564    most recent
M105189200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeidner, G.
Right arrow Articles by Reuveny, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeidner, G.
Right arrow Articles by Reuveny, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Redox-dependent Gating of G Protein-coupled Inwardly Rectifying K+ Channels*

Gil Zeidner, Rona Sadja, and Eitan ReuvenyDagger

From the Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel

Received for publication, June 6, 2001, and in revised form, July 10, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

G protein-coupled inwardly rectifying K+ channels (GIRK) play a major role in inhibitory signaling in excitable and endocrine tissues. The gating mechanism of these channels is mediated by a direct interaction of the Gbeta gamma subunits of G protein, which are released upon inhibitory neurotransmitter receptor activation. This gating mechanism is further manifested by intracellular factors such as anionic phospholipids and Na+ and Mg2+ ions. In addition to the essential role of these components for channel function, phosphorylation events can also modulate channel activity. In this study we explored the involvement of redox modulation on GIRK channel function. Extracellular application of the reducing agent dithiothreitol (DTT), but not reduced glutathione, activated GIRK channels without affecting their permeation or rectification properties. The DTT-dependent activation was found to mimic receptor activation and to act directly on the channel in a membrane delimited fashion. A critical cysteine residue located in the N-terminal cytoplasmic domain was found to be essential for DTT-dependent activation in hetero- and homotetrameric contexts. Interestingly, when mutating this cysteine residue, DTT-dependent activation was abolished, but receptor-mediated channel activation was not affected. These results suggest that intracellular redox potential can play a major role in tuning GIRK channel activity in a receptor-independent manner. This sort of redox modulation can be part of an important cellular protective mechanism against ischemic or hypoxic insults.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

G protein-coupled inwardly rectifying K+ channels (GIRK)1 couple inhibitory neurotransmission in brain, heart, and endocrine tissues to membrane hyperpolarization. In the brain they are mainly responsible for the generation of slow inhibitory postsynaptic potentials (1), and in the heart they are involved in slowing of the heart rate in response to vagal stimulation (2). The activation of GIRK channels by inhibitory neurotransmission is triggered by the Gbeta gamma subunits of the G protein (3-5). This Gbeta gamma -channel interaction involves binding of Gbeta gamma to both the N- and C-terminal cytoplasmic domains (6-12), which appears to drive a rearrangement of the pore-forming second transmembrane alpha -helix (TM2) to open the channel (13, 14). The Gbeta gamma -mediated gating of the channel can be aided by other intracellular components. Sodium and Mg2+ ions have been found to interact with the C-terminal cytoplasmic domain of the channel to fine-tune channel gating mediated by the anionic phospholipid, phosphatidylinositol-4,5-bisphosphate (15-19), which is an obligatory component for the stability of the open state of the channel (14). The Na+-phosphatidylinositol-4,5-bisphosphate interaction can also serve as a mechanism for modulating by external ligands (20). In addition to the modulatory action of the various ionic species mentioned above, channel function can also be tuned by phosphorylation/dephosphorylation events. Activation of TrkB receptors by neurotrophin brain-derived neurotrophic factor affects channel function via tyrosine phosphorylation (21), and activation of cAMP formation via beta 2-adrenergic receptors facilitates channel function (22). These phosphorylation events may act by affecting the interaction of the Gbeta gamma subunits with the channel by occluding the Gbeta gamma binding site (23). Additionally, inhibitory signaling can occur via protein kinase C modulation by an as yet unknown mechanism (24-26).

Several studies have shown that redox signaling can serve as an additional mechanism to modulate ion channel activity to link the metabolic state of the cell to its electrical properties (for review see Refs. 27 and 28). Redox signaling has been found to affect the activity of several ion channels, such as the N-methyl-D-aspartate receptor, NR1 (29), the Ca2+-activated K+ channel, hslo (30), ryanodine receptor (31), a voltage gated K+ channel, Kv1.4 (32), and the inwardly rectifying K+ channel, IRK1 (33). In this study we examined the role of redox potential in mediating GIRK channel activity expressed in Xenopus oocytes. Exposure of GIRK channels to the membrane-permeable redox agent, dithiothreitol (DTT), but not impermeable glutathione (GSH), increased channel activity in a reversible manner when monitored under intact whole cell conditions. This effect of DTT was specifically attributed to an N-terminal cytosolic cysteine residue, as mutating this residue abolished DTT action without affecting receptor-mediated channel activation. In this study, we suggest that an increase of GIRK channel activity by redox signaling can serve as a protective cellular mechanism under hypoxic or ischemic insults.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Oocyte Preparation-- All channels and their mutants were subcloned into pGEMHE expression vector (34). Oocytes were prepared as described previously (14). Healthy-looking stage 5-6 oocytes were selected and micro-injected with 50 nl of cRNA of the various channel mutant cRNA alone (~0.1-5 ng) or with human m2 muscarinic receptor (~.5 ng), Gbeta 1gamma 2 (~1 ng each), cbeta ARK (C-terminus of beta -adrenergic receptor kinase, ~1 ng) (35), or PTX-S1 (36) (~1 ng). All recordings were made 3-14 days post-injection.

Site-directed Mutagenesis-- Site-directed mutagenesis was done based on polymerase chain reaction of full-length plasmid using the high fidelity Pfu polymerase (method by Stratagene). Positive clones were verified by sequencing.

Electrophysiology-- Currents through the expressed channels were recorded using the two-electrode voltage clamp technique as previously described (14). Oocytes were held at 0 mV unless otherwise indicated, and voltage ramps from -100 mV to +50 mV for 0.6 s were applied. The oocytes were washed for at least 2 min with 90K solution containing 90 mM KCl, 10 mM HEPES, 2 mM MgCl2, pH 7.4 (KOH) before data collection. In all experiments presented, oocytes expressing less than 10 µA of current at -100 mV were used.

Single-channel currents were measured by the inside-out configuration of the patch-clamp technique using an Axopatch 200B amplifier as previously described (14). The pipette solution contained 140 mM KCl, 5 mM HEPES, 0.5 mM EGTA, 0.5 mM EDTA, pH 7.4. The FVPP bath solution contained 140 mM KCl, 10 mM HEPES, 10 mM EGTA, 10 mM Na2H2P2O7, 5 mM NaF, 0.1 mM Na3VO4, 5 mM NaOH, pH 7.2, N-methyl-D-glucamine (NMG) (37). DTT and GSH were diluted from 1 and 0.5 M stock solutions, respectively, before use.

Statistical and Data Analysis-- Data are presented as fold induction means ± S.E., and n denotes the number of oocytes assayed. A t test was used to calculate the statistical significance of differences between different populations.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We were interested in testing the effect of the reducing agent, DTT, on GIRK1/4 channel function. Two electrode voltage clamp recordings of Xenopus oocytes expressing GIRK1 and GIRK4 display inwardly rectifying currents upon application of voltage ramp protocols from -100 to +50 mV. Upon the application of 10 mM DTT to the extracellular solution in the absence of expressed G protein coupled receptors and agonists of native receptors, a gradual increase in basal inwardly rectifying current is apparent that reaches a maximum steady state induction within 10 min of application and reverses upon DTT washout to base-line levels (Fig. 1, A and B). The average induction of GIRK1/4 channel currents was 2.62 ± 0.20-fold (n = 12) (Fig. 1C). The DTT-induced currents did not change the rectification characteristics monitored at +50 mV (Fig. 1, A and B) and did not change ion selectivity (K+ versus Na+, data not shown). Thus, these results suggest that the selective increase in membrane current by DTT is mainly due to an increase in activity of GIRK1/4 channels. In control experiments, DTT had no effect on uninjected oocyte basal current levels. To assess the dose dependence of DTT action on GIRK1/4 channel currents, we measured current levels in response to a series of DTT solutions of increasing concentrations. We found that the DTT concentration that induced 50% of the maximal increase in basal GIRK1/4 currents was 1.93 ± 0.89 mM, with a Hill coefficient of 0.84 ± 0.32 (Fig. 1D). To test whether DTT action is intracellular, we also tested the effect of the non-permeant reducing agent GSH on channel currents. GSH, at 10 mM, did not induce an increase in current (0.68 ± 0.05-fold (n = 6) induction), suggesting that the action site of DTT is intracellular (Fig. 1C).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 1.   DTT activates GIRK channels expressed in Xenopus oocytes in a membrane-delimited manner. A, time course of GIRK current induction by 10 mM DTT applied to the extracellular solution for 10 min and the return to basal current levels after washout. Current levels at +50 and -50 mV were taken from ramps (-100 to +50 mV for 1 s) applied every 2 s from a holding potential of 0 mV. B, representative ramps before (1), during (2), and after (3) induction by DTT. Ramps were taken at the indicated times marked by the numbered arrows in A. C, bar graph summarizing the effect of DTT and GSH on GIRK1/4 and the effect of DTT on IRK1 channel currents. D, cumulative dose response curve for DTT induction of GIRK1/4 channels. GIRK1/4 steady state induction was normalized to the induction achieved by 30 mM DTT at the end of a 10-min application. Points were fitted to the Hill equation with EC50 for DTT induction of 1.93 ± 0.89 mM.

We also wanted to test whether the effect seen with DTT on GIRK1/4 channel currents was specific for the GIRK family. We therefore tested the effect of DTT using the same protocols as above on the G protein-independent inwardly rectifying K+ channel, IRK1. DTT had no stimulatory effect on the IRK1 currents but, rather, induced a slight inhibition 0.79 ± 0.17- fold (n = 6) (Fig. 1D). The decrease in IRK1 currents by DTT has been seen before by Ruppersberg et al. (33). We then tested whether the DTT effect depends on soluble components endogenously present in the oocyte cytosol.

To further verify that the lack of GSH to induce channel activity was due to its inability to cross the plasma membrane, we performed single channel recordings on excised inside-out patches and tested the effect of 1 mM DTT or 10 mM GSH applied to the cytosolic face of the patch. Extensive washes of the inner face of the patches did not abolish the DTT or the GSH effect. Both DTT and GSH increased the probability of channel openings without affecting the single channel amplitude measured at -100 mV (Fig. 2, A and B). Interestingly, extensive washout (for at least 5 min) was not able to reverse either the DTT or the GSH effects, and the channels remained as active as in the presence of the corresponding reducing agent. Thus, these results suggest that the action of DTT to induce channel activation is membrane-delimited, and the reversibility of this effect (as seen under whole cell measurements, Fig. 1A) may depend on the cytoplasmic factor(s) that is absent in the excised patch.


View larger version (54K):
[in this window]
[in a new window]
 
Fig. 2.   Both DTT and GSH are able to activate GIRK1/4 channel when applied to the cytoplasmic side of the membrane. Single channel current traces under excised patch condition in the absence (left) and in the presence of 1 mM DTT (A) and 10 mM GSH (B) and following extensive washout (right). Current traces are shown in two different time scales (above 1 min and below 1.2 s/trace). These patches were held at -100 mV and contained at least three channels.

In native tissue, GIRK1/4 channels are activated by neurotransmitter receptor stimulation, and so we were interested in examining the nature of DTT channel induction in relation to activation by the type 2 muscarinic receptor (m2R). Oocytes were co-injected with GIRK1/4 channel and m2R, and the effect of DTT was tested in the presence and absence of receptor stimulation using 3 µM carbachol. Receptor-mediated channel activity was measured after 30 s of application of carbachol in the presence and in the absence of 10 mM DTT (Fig. 3A). Carbachol application alone increased the GIRK1/4 currents by 6.6 ± 0.7-fold (n = 8), and carbachol application in addition to DTT increased the current by 6.7 ± 0.5-fold (Fig. 3B). This indicates that DTT induction of the GIRK1/4 channel is not additive to receptor stimulation and, thus, may act on the same activation pathway or on a converged one. To further explore this possibility, we tested whether DTT is able to induce channel currents once channels are fully activated, independent of receptor stimulation. One way to fully activate the channels is by the co-expression of the channel with the Gbeta 1gamma 2 subunits of the G protein (4). Application of 10 mM DTT to oocytes co-expressing GIRK1/4 channels and Gbeta 1gamma 2 induced an increase in currents with 1.34 ± 0.11-fold (n = 5) induction (Fig. 4A), but as with receptor stimulation, this effect was occluded in that it was considerably smaller that the 2.6-fold induction seen in the absence of Gbeta gamma . An alternate way to test the effect of DTT on fully activated GIRK1/4 channels is to use constitutively active, Gbeta gamma -independent channel mutants (14). These mutations, localized to the TM2 domain of the channel, lock the channel in its activated conformation. We tested two of these mutants, GIRK1(C179A)/GIRK4(C185A) and GIRK1(S170P)/GIRK4(S176P). Once again, DTT had a considerably attenuated induction of channel currents, with 1.24 ± 0.06 (n = 5) and 1.19 ± 0.07-fold (n = 8) induction for the two mutants, respectively (Fig. 4A). The reduced ability of DTT to induce channel activity in activated channels suggests that the action of DTT may be to mimic Gbeta gamma -dependent activation.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 3.   The lack of additivity in the action of DTT and receptor activation on GIRK channels. A, time course of GIRK1/4 channel induction by m2R activation (3 µM carbachol) in the absence and in the presence of 10 mM DTT. Current levels were measured as depicted in Fig. 1. Carbachol (Carb.) was applied for 30 s to estimate the total induced current. B, bar graph summarizing the fold induction of GIRK1/4 channel currents in the absence and in the presence of DTT. No significant difference was seen between these two conditions.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   DTT is ineffective on fully activated channel and does not directly activate G proteins. A, bar graph summarizing the effect of 10 mM DTT application on fully activated GIRK1/4 channels by either co-expressing Gbeta 1gamma 2 subunits or on constitutively active GIRK1(C179A)/GIRK4(C185A) and GIRK1(S170P)/GIRK4(S176P) mutant channels. B, bar graph summarizing the full effectiveness of 10 mM DTT in activating GIRK1/4 channels co-expressed with the Gbeta gamma binding domain of beta -adrenergic receptor kinase 1 (cbeta ARK), the catalytic subunit of pertussis toxin (PTX-S1), or Galpha s subunit of the G protein. C, bar graph summarizing the inability of 3 µM carbachol to activate GIRK1/4 channels co-expressed with either cbeta ARK (C-terminus of beta -adrenergic receptor kinase) or PTX-S1, demonstrating that either trapping Gbeta gamma or preventing it from dissociating from the G protein trimer is sufficient to block m2R stimulation without affecting DTT induction (B).

Two possibilities are likely to explain the above results. The action of DTT could be the consequence of direct reduction of the channel, and the second possibility involves DTT activation of either the G protein trimers to release Gbeta gamma or of another second messenger system. To address the latter possibility, we tested the ability of DTT to induce channel currents under three different conditions that reduce the levels of free Gbeta gamma in the oocyte. The first way was by co-expressing the catalytic subunits of pertussis toxin (PTX-S1). PTX-S1 induces ADP-mediated ribosylation of the Galpha i/o subunit of the G protein and prevents the release of Gbeta gamma . The second way to reduce free Gbeta gamma levels in the oocyte was by expressing the C-terminal end of the beta -adrenergic receptor kinase (C-beta ARK), which has been shown to bind the Gbeta gamma subunits of G proteins (38) and, thus, to reduce channel activity (4). The third way to reduce Gbeta gamma levels was by the co-expression of Galpha s, with the idea that an excess of Galpha s will act as a large sink for free Gbeta gamma subunits (39). As expected, under the first two conditions, m2R activation was impaired (Fig. 4C). However, the DTT induction was not significantly affected (Fig. 4B). DTT induction for co-expression with PTX-S1, C-beta ARK (C-terminal end of the beta -adrenergic receptor kinase), or Galpha s was 2.2 ± 0.2, 1.9 ± 0.3, and 2.9 ± 0.8-fold, respectively. These results suggest that DTT activates GIRK1/4 channels without a direct activation of G proteins.

As discussed above, protein kinases may regulate GIRK channel activity. To rule out any involvement of protein kinase A or protein kinase C in DTT action, we used the potent nonspecific protein kinase inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride (H7). Oocytes expressing GIRK1/4 channels were incubated in 100 µM H7 for at least 20 min before recordings, and the action of DTT was then tested. Incubation with H7 failed to affect DTT stimulatory action, with DTT induction of 2 ± 0.3-fold. These results suggest that the action of DTT on the channel is not mediated through the activation of protein kinase A or protein kinase C in the oocytes.

Recently, it has become evident that many proteins undergo specific post-translational modification on cysteine residues, mainly by the use of nitric oxide donors, to form nitrosylated cysteines (for review, see ref. 40). Thus, another possible target for DTT action is the breakdown of a nitrosylated cysteine that participates in channel regulation. We explored this possibility using two independent approaches to modify nitric oxide levels; those approaches were either by using a nitrosothiol derivative that releases nitric oxide, S-nitroso-N-acetylpenicillamine, or by direct inhibition of nitric oxide synthase using NG-nitro-L-arginine methyl ester. These compounds had no affect on channel function, receptor activation, or basal channel activity (not shown). In addition, it is also worth noting that the critical negative residue essential for the acid-base catalysis of sulfahydryl nitrosylation, which should flank potential nitrosylated cysteines, is not present around cysteines in either GIRK1 or GIRK4 (41). These results thus suggest that GIRK channels are not regulated by nitrosylation, and the effect of DTT is probably not mediated through this pathway.

The above results suggest that DTT may mediate channel induction via direct reduction of cytoplasmic cysteines of the channel molecule. GIRK1 and GIRK4 contain seven and eight cysteine residues, respectively, including two extracellular conserved residues at positions 123 and 156 in GIRK1 and at positions 129 and 162 in GIRK4. These cysteines are fully conserved in all inwardly rectifying K+ channels and have been shown to be important for the assembly of IRK-like channels (42-44). There is an additional cysteine located in the TM2 domain that is conserved in all members of the GIRK and K-ATP channel families. This cysteine has been shown to be involved in Gbeta gamma -mediated gating conformation (14). Alignment of the Kir family members reveals another conserved residue at the intracellular N terminus of the channel, at positions 53 and 60 in GIRK1 and GIRK4, respectively. The remaining intracellular cysteines are located in the C-terminal cytosolic domain of the channel (Fig. 5A). All six GIRK4 intracellular cysteines were replaced, and the channel mutants were co-expressed with wild type GIRK1 channel. We found that none of the single cysteine substitutions affected the ability of DTT to induce channel currents (Fig. 5B). The following GIRK4 mutants co-expressed with GIRK1 were induced by DTT by: C60A, 1.98 ± 0.20 (n = 5)-fold; C216A, 3.32 ± 0.66 (n = 5)-fold; C316T, 1.85 ± 0.18 (n = 5)-fold; C362A + C363S, 1.84 ± 0.11 (n = 5)-fold; C389A, 1.86 ± .07 (n = 5)-fold (Fig. 5C).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 5.   DTT does not require all cytosolic cysteines in a heterotetrameric context for its action. A, a schematic depicting the extracellular and transmembrane (light gray) and presumed cytosolic (black) cysteine residues of GIRK4 channels. B, time course of DTT action on oocytes co-expressing various GIRK4 cysteine mutants with GIRK1 wild-type. The dashed line represents a zero current level; above and below are the measured current levels at +50 mV and -50 mV, respectively. Scale bars are 1 µA and 60 s. C, bar graph summarizing the DTT induction of the various GIRK4 cysteine mutants co-expressed with GIRK1 wild-type channel. There is no statistical difference between the induction of the GIRK1/GIRK4 and the GIRK1/GIRK4 cysteine mutants.

Since removing individual cysteines from GIRK4 in the heteromultimeric context was not sufficient to affect DDT action, we wanted to test whether removing all intracellular cysteines in a homomultimeric context would have an effect. To simplify the possible mutant combinations we used a GIRK4 mutant, GIRK4(S143T), that has been shown to form functional homotetramers (36) and tested the ability of DTT to induce its currents. Fig. 6A represents a time course of DTT induction of the GIRK4(S143T) channel. DTT was able to induce GIRK4(S143T) channel currents in a similar manner to the GIRK1/4 heteromultimer with 2.3 ± 0.3-fold induction. We then removed all intracellular cysteines in the background of the S143T mutation and tested the effect of DTT (Fig. 6B). DTT failed to affect the homomeric GIRK4(S143T), lacking all six intracellular cysteines (C60A, C216A, C316T, C362A, C363S, and C389A), with 0.8 ± 0.23-fold induction (Fig. 6D), without affecting m2R activated currents (Fig. 6C). This first suggests that the action of DTT on induction of channel currents is probably mediated through the channel intracellular cysteines and, second, that the mechanism by which DTT induces activity and receptor-mediated activation are via two separate pathways.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 6.   DTT induction of the GIRK4(S143T) homomeric mutant and the lack of induction once the cytoplasmic cysteines are removed. A, time course of 3 µM carbachol (Carb.) and of 10 mM DTT induction of the GIRK4(S143T) homomultimer. Current measurements were taken as described in Fig. 1. B, time course of 3 µM carbachol and 10 mM DTT induction of GIRK4(S143T) channel lacking all intracellular cysteines (C60A, C216A, C316T, C362A, C363S, and C389A). Note the intact ability of carbachol to gate the mutated channel and the impaired DTT induction. C, bar graph summarizing the extent of channel induction by carbachol of GIRK4(S143T) and of the mutant lacking all intracellular cysteines. D, bar graph summarizing fold induction by 10 mM DTT of GIRK4(S143T) and its various cysteine mutants (as indicated). Note the lack of effect of DTT when the N-terminal C60A mutation is present.

We set out to identify the cysteine residue responsible for DTT induction in the homomeric GIRK4(S143T) context. We therefore mutated all intracellular cysteines in groups according to their location in the linear sequence of the channel. All channel mutants that contained the C60A mutation failed to respond to DTT (Fig. 6D). Thus, these results suggest that the cysteine residue at position C60 is involved in channel activation by DTT. Since in native tissues most of the GIRK channel combinations form heteromultimers, we also wanted to test whether mutating the analogous cysteines at position Cys-53 and Cys-60 in GIRK1 and GIRK4, respectively, would affect DTT induction. GIRK1(C53A)/GIRK4(C60A) mutant channels failed to respond to DTT, as seen in the homomultimeric context (Fig. 7A), without affecting the ability of carbachol to induce currents (Fig. 7B). These results again suggest that the N-terminal cysteines at positions Cys-53 and Cys-60 in GIRK1 and GIRK4, respectively, play a critical role in DTT action without affecting receptor-mediated activation.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 7.   Impaired DTT induction of the N-terminal cysteine mutation in a heteromultimeric context. A, bar graph summarizing the inability of 10 mM DTT to activate the GIRK1(C53A)/GIRK4(C60A) mutant. For purposes of comparison, the bar graph of the wild-type is the same as in Fig. 1. B, bar graph summarizing the ability of 3 µM carbachol (Carb.) to gate the above N-terminal cysteine channel mutant. Note that carbachol induction is not affected, similar to the situation with the homomeric channel described in Fig. 6.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this paper, we report a novel mechanism to modulate GIRK channel gating; that is, reduction of a conserved cysteine residue in the N-terminal cytosolic domain. This form of gating may operate in parallel to the action of the classical activators of the channel, the Gbeta gamma subunits of the G protein, phospholipids and Na+ ions. From the experiments presented above we suggest that reduction by DTT mimics gating of the channel by Gbeta gamma subunits. Several lines of evidence contribute to this conclusion. First, GIRK currents are activated by DTT without a change in rectification and selectivity. Second, the effect of DTT is reduced with receptor-mediated GIRK channel activation and with the constitutive activation caused by overexpressing Gbeta 1gamma 2. Third, channels that are constitutively active and Gbeta gamma -independent (14) abolish the DTT-mediated induction. These results may suggest that the cysteine reduction mechanism involves a similar conformation of the gating apparatus as induced by receptor stimulation or the Gbeta gamma subunits but, interestingly, without affecting channel rectification.

The failure of DTT to affect channel rectification is the most apparent difference in channel biophysical properties between activation by receptor stimulation and DTT. In the former case, the extent of channel rectification during activation is reduced, and hence, more current is apparent at potentials above the equilibrium for K+ ions (for example, see Fig. 3A traces at +50 mV). In the latter situation, DTT activation gating does not affect channel rectification. One plausible explanation for this difference is that DTT opens GIRK1/4 channels to a state where the gate is open but does not undergo an additional transition normally induced by a full receptor-dependent activation. This full transition gating state induced by receptor stimulation of the channel may suggest that Gbeta gamma interaction, unlike DTT induction, affects channel conformation by reducing the binding of either Mg2+ ions or polyamines. This may be due to the ability of Gbeta gamma to strongly interact with the C-terminal cytoplasmic domain of the channel and induce a conformational change in the second transmembrane domain of the channel (13, 14). These two regions are known to interact with the components responsible for inward rectification, Mg2+ ions and polyamines (Ref. 45 and 46; for review, see also Ref. 47). The robust capacity of Gbeta gamma to gate the channel compared with DTT is also evident by the ~2-fold less efficient channel activation by DTT.

Does DTT directly act on the channel molecule, or is its action mediated via a second mediator? Such mediated action could involve DTT activation of the G protein-coupled receptor, the G protein, or of another second-messenger system. First, we can exclude the possibility that DTT acts directly on the G protein-coupled receptor (48) because 1) the effect of DTT was seen with oocytes expressing only the GIRK channel, without the m2R receptor, and 2) co-expression of the channel and the receptor with the catalytic subunit of pertussis toxin abolished receptor-mediated activation (36) but did not affect the ability of DTT to induce channel currents. Second, we can also exclude the possibility that DTT directly activates the G protein trimer to release Gbeta gamma subunits. This is because co-expression of the GIRK channel with either Galpha s or the C terminus of beta ARK, both of which reduce the availability of free Gbeta gamma (35, 39), did not affect DDT induction, even though it dramatically reduced receptor-mediated activation. This indicates that DTT-mediated channel induction does not involve a direct activation of G proteins in the oocyte. Third, we can also exclude the involvement of protein kinase activation by DTT, since the nonspecific kinase inhibitor, H7, was unable to abolish DTT induction, and fourth, we can exclude the involvement of nitrosylation in DTT action. We therefore can suggest that DTT action is a direct effect on the channel molecule to induce an activated conformation.

The proposal that the DTT effect on GIRK gating is direct is further supported by the finding that the DTT effect is eliminated by removal of all of the intracellular cysteines from the GIRK4(S143T) homomultimeric channel. By systematically eliminating individual cysteines from this homomeric channel, it becomes apparent that only the N-terminal cytosolic cysteine at position 60 is essential for DTT-mediated activation. Moreover, from experiments using co-expression of GIRK1 wild type and GIRK4(C60A) mutant channels, it is apparent that it is not obligatory to have N-terminal cysteines in all four channel subunits for DTT to gate the channel (Fig. 5C). Since experiments involving tandemly linked different GIRK channel subunits point toward a specific preferred architecture of functional channels, alternating GIRK1/GIRK4 monomers (49, 50), it becomes plausible to conclude that N-terminal cysteines from neighboring subunits are not involved in DTT action. Once the N-terminal cysteines are removed from both subunits, GIRK1(C53A) and GIRK4(C60A), DTT is no longer able to activate the channel. Thus, if indeed the action of DTT is to mediate the reduction of disulfide bridges, they should exist between diagonal subunits, which will require the opposing N-terminal cytosolic domains to be within a few angstroms of each other, as the length between two thio groups forming disulfide bond is about 2 Å. Alternatively, the N-terminal cysteines can be oxidized at their sulfhydryl group (at physiological pH) to become reactive cysteines (thiolate, S-). This reactivity can be stabilized by positively charged amino acids neighboring these cysteines, as seen in the bacterial transcription factor OxyR (51). Interestingly, in the GIRK channel family, there is a lysine side chain immediately preceding the N-terminal cysteines, which is not found in the IRK channel family. These reactive cysteines can form sulfenic ion (S-OH) under very mild oxidation that can cause them to interact with the high levels of intracellular GSH to form mixed disulfides (28). Due to the lower reducing potential of DTT compared with GSH, DTT may act to reduce this mixed disulfide to the sulfhydryl form. The equilibrium between the mixed disulfide and sulfhydryl or reactive cysteine species may determine the receptor-independent activity of the channel. The fact that DTT induction is reversible only under intact whole cell and not under excised patch configuration suggests that cytosolic factors, e.g. thioredoxin or glutaredoxin, may be involved in the reversal of DTT induction. We thus hypothesize that the cysteines in the N-terminal cytoplasmic domain of the channel can undergo an oxidation-reduction cycle to modulate channel activity.

What is the physiological relevance of redox-mediated GIRK channel activation? In the past few years it has become more appreciated that redox signaling at low concentrations of reactive oxygens may play a major role in regulating many cellular events such as cell-cell adhesion, immunological responses, and cellular excitability (for review, see Refs. 52 and 53). Under hypoxic or ischemic conditions, when the oxygen tension is reduced, activation of GIRK channels may be of great importance, specifically in reducing cellular excitability by hyperpolarization. For example, in CA1 pyramidal neurons hypoxia causes hyperpolarization, which is independent of opening of K-ATP, Ca2+-activated K+ or Cl- channels (54). This form of GIRK channel control by redox modulation can serve as a control to reduce excitability independent of synaptic activity. In the case of the heart it has been proposed that ischemic preconditioning, a protective mechanism in which a brief period of myocardial ischemia renders the myocardium resistant to a more sever ischemic insult (55), is mediated by a pertussis toxin-sensitive mechanism that involves acetylcholine and adenosine (56). Although most of the published observations point toward the involvement of mitochondrial K-ATP channels in this protection during preconditioning ischemic insults (57), it is interesting to note that both neurotransmitters also activate GIRK channels in atrial myocytes. This relation raises the possible involvement of GIRK channels in this protective action, specifically the anti-arrhythmic aspect of preconditioning.

In summary, the present work identifies a novel aspect of GIRK channel gating in which the redox state can modulate channel gating. An increase in redox potential opens the GIRK channel without affecting the permeation properties of the channel. We identify a single conserved residue located in the N terminus of the channel as the main mediator of this action. This redox-dependent gating is an additional gating mechanism to neurotransmitter-receptor activation, which underlies its importance as a potential protective mechanism in cases of ischemic or hypoxic shock, mainly by membrane hyperpolarization to reduce cellular excitability.

    ACKNOWLEDGEMENTS

We thank Dr. A. Danon for helpful discussions, Dr. E. Y. Isacoff and N. Alagem for reading the manuscript and for discussions, and R. Meller and E. Shalgi for excellent technical assistance.

    FOOTNOTES

* This work was supported by the Israeli Science Foundation, the Minerva Foundation (Germany), the Human Frontier Science Program, and the Buddy Taub Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 972-8-934-3243; Fax: 972-8-934-2135; E-mail: e.reuveny@weizmann.ac.il.

Published, JBC Papers in Press, July 20, 2001, DOI 10.1074/jbc.M105189200

    ABBREVIATIONS

The abbreviations used are: GIRK, G protein-coupled inwardly rectifying potassium channels; Gbeta gamma , G protein beta  and gamma  subunits; DTT, dithiothreitol; TM2, second transmembrane alpha -helix; IRK1, inward rectifier type Kir2.1; PTX-S1, catalytic subunits of pertussis toxin; m2R, type 2 muscarinic receptor.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Luscher, C., Jan, L. Y., Stoffer, M., Malenka, R. C., and Nicoll, R. A. (1997) Neuron 19, 687-695
2. Wickman, K., Nemec, J., Gendler, S. J., and Clapham, D. E. (1998) Neuron 20, 103-114
3. Logothetis, D. E., Kurachi, Y., Galper, J., Neer, E. J., and Clapham, D. E. (1987) Nature 325, 321-326
4. Reuveny, E., Slesinger, P. A., Inglese, J., Morales, J. M., Iniguez-Lluhi, J. A., Lefkowitz, R. J., Bourne, H. R., Jan, Y. N., and Jan, L. Y. (1994) Nature 370, 143-146
5. Wickman, K. D., Iniguez-Lluhl, J. A., Davenport, P. A., Taussig, R., Krapivinsky, G. B., Linder, M. E., Gilman, A. G., and Clapham, D. E. (1994) Nature 368, 255-257
6. Huang, C. L., Jan, Y. N., and Jan, L. Y. (1997) FEBS Lett. 405, 291-298
7. Huang, C. L., Slesinger, P. A., Casey, P. J., Jan, Y. N., and Jan, L. Y. (1995) Neuron 15, 1133-1143
8. Inanobe, A., Morishige, K. I., Takahashi, N., Ito, H., Yamada, M., Takumi, T., Nishina, H., Takahashi, K., Kanaho, Y., Katada, T., and Kurachi, Y. (1995) Biochem. Biophys. Res. Commun. 212, 1022-1028
9. Krapivinsky, G., Krapivinsky, L., Wickman, K., and Clapham, D. E. (1995) J. Biol. Chem. 270, 29059-29062
10. Kunkel, M. T., and Peralta, E. G. (1995) Cell 83, 443-449
11. Slesinger, P. A., Reuveny, E., Jan, Y. N., and Jan, L. Y. (1995) Neuron 15, 1145-1156
12. He, C., Zhang, H., Mirshahi, T., and Logothetis, D. E. (1999) J. Biol. Chem. 274, 12517-12524
13. Yi, B. A., Lin, Y., Jan, Y. N., and Jan, L. Y. (2001) Neuron 29, 657-667
14. Sadja, R., Smadja, K., Alagem, N., and Reuveny, E. (2001) Neuron 29, 669-680
15. Petit-Jacques, J., Sui, J. L., and Logothetis, D. E. (1999) J. Gen. Physiol. 114, 673-684
16. Zhang, H., He, C., Yan, X., Mirshahi, T., and Logothetis, D. E. (1999) Nat. Cell Biol. 1, 183-188
17. Sui, J. L., Chan, K. W., and Logothetis, D. E. (1996) J Gen Physiol 108, 381-391
18. Sui, J. L., Petit-Jacques, J., and Logothetis, D. E. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 1307-1312
19. Lesage, F., Guillemare, E., Fink, M., Duprat, F., Heurteaux, C., Fosset, M., Romey, G., Barhanin, J., and Lazdunski, M. (1995) J. Biol. Chem. 270, 28660-28667
20. Rogalski, S. L., and Chavkin, C. (2001) J. Biol. Chem. 276, 14855-14860
21. Rogalski, S. L., Appleyard, S. M., Pattillo, A., Terman, G. W., and Chavkin, C. (2000) J. Biol. Chem. 275, 25082-25088
22. Mullner, C., Vorobiov, D., Bera, A. K., Uezono, Y., Yakubovich, D., Frohnwieser-Steinecker, B., Dascal, N., and Schreibmayer, W. (2000) J. Gen. Physiol. 115, 547-558
23. Medina, I., Krapivinsky, G., Arnold, S., Kovoor, P., Krapivinsky, L., and Clapham, D. E. (2000) J. Biol. Chem. 275, 29709-29716
24. Vorobiov, D., Levin, G., Lotan, I., and Dascal, N. (1998) Pfluegers Arch. Eur. J. Physiol. 436, 56-68
25. Sharon, D., Vorobiov, D., and Dascal, N. (1997) J. Gen. Physiol. 109, 477-490
26. Mark, M. D., Ruppersberg, J. P., and Herlitze, S. (2000) Neuropharmacology 39, 2360-2373
27. Peers, C. (1997) Trends Pharmacol. Sci. 18, 405-408
28. Finkel, T. (2000) FEBS Lett. 476, 52-54
29. Sullivan, J. M., Traynelis, S. F., Chen, H. S., Escobar, W., Heinemann, S. F., and Lipton, S. A. (1994) Neuron 13, 929-936
30. DiChiara, T. J., and Reinhart, P. H. (1997) J. Neurosci. 17, 4942-4955
31. Haarmann, C. S., Fink, R. H., and Dulhunty, A. F. (1999) Biophys. J. 77, 3010-3022
32. Ruppersberg, J. P., Stocker, M., Pongs, O., Heinemann, S. H., Frank, R., and Koenen, M. (1991) Nature 352, 711-714
33. Ruppersberg, J. P., and Fakler, B. (1996) Neuropharmacology 35, 887-893
34. Liman, E. R., Tytgat, J., and Hess, P. (1992) Neuron 9, 861-871
35. Jing, J., Chikvashvili, D., Singer-Lahat, D., Thornhill, W. B., Reuveny, E., and Lotan, I. (1999) EMBO J. 18, 1245-1256
36. Vivaudou, M., Chan, K. W., Sui, J. L., Jan, L. Y., Reuveny, E., and Logothetis, D. E. (1997) J. Biol. Chem. 272, 31553-31560
37. Huang, C. L., Feng, S., and Hilgemann, D. W. (1998) Nature 391, 803-806
38. Pitcher, J. A., Inglese, J., Higgins, J. B., Arriza, J. L., Casey, P. J., Kim, C., Benovic, J. L., Kwatra, M. M., Caron, M. G., and Lefkowitz, R. J. (1992) Science 257, 1264-1267
39. Lim, N. F., Dascal, N., Labarca, C., Davidson, N., and Lester, H. A. (1995) J. Gen. Physiol. 105, 421-439
40. Stamler, J. S., and Meissner, G. (2001) Physiol. Rev. 81, 209-237
41. Stamler, J. S., Toone, E. J., Lipton, S. A., and Sucher, N. J. (1997) Neuron 18, 691-696
42. Bannister, J. P., Young, B. A., Sivaprasadarao, A., and Wray, D. (1999) FEBS Lett. 458, 393-399
43. Cho, H. C., Tsushima, R. G., Nguyen, T. T., Guy, H. R., and Backx, P. H. (2000) Biochemistry 39, 4649-4657
44. Leyland, M. L., Dart, C., Spencer, P. J., Sutcliffe, M. J., and Stanfield, P. R. (1999) Pfluegers Arch. Eur. J. Physiol. 438, 778-781
45. Kubo, Y., and Murata, Y. (2001) J. Physiol. 531, 645-660
46. Yang, J., Jan, Y. N., and Jan, L. Y. (1995) Neuron 14, 1047-1054
47. Nichols, C. G., and Lopatin, A. N. (1997) Annu. Rev. Physiol. 59, 171-191
48. Pedersen, S. E., and Ross, E. M. (1985) J. Biol. Chem. 260, 14150-14157
49. Silverman, S. K., Lester, H. A., and Dougherty, D. A. (1996) J. Biol. Chem. 271, 30524-30528
50. Tucker, S. J., Pessia, M., and Adelman, J. P. (1996) Am. J. Physiol. 271, H379-H385
51. Zheng, M., Aslund, F., and Storz, G. (1998) Science 279, 1718-1721
52. Sen, C. K. (1998) Biochem. Pharmacol. 55, 1747-1758
53. Kourie, J. I. (1998) Am. J. Physiol. 275, C1-C24
54. Hyllienmark, L., and Brismar, T. (1999) Neuroscience 91, 511-517
55. Murry, C. E., Jennings, R. B., and Reimer, K. A. (1986) Circulation 74, 1124-1136
56. Schultz, J. E., Hsu, A. K., Barbieri, J. T., Li, P. L., and Gross, G. J. (1998) Am. J. Physiol. 275, H495-H500
57. Cohen, M. V., Baines, C. P., and Downey, J. M. (2000) Annu. Rev. Physiol. 62, 79-109


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
L.-M. Fan, W. Zhang, J.-G. Chen, J. P. Taylor, A. M. Jones, and S. M. Assmann
Abscisic acid regulation of guard-cell K+ and anion channels in G{beta}- and RGS-deficient Arabidopsis lines
PNAS, June 17, 2008; 105(24): 8476 - 8481.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Hinzpeter, J. Fritsch, F. Borot, S. Trudel, D.-L. Vieu, F. Brouillard, M. Baudouin-Legros, J. Clain, A. Edelman, and M. Ollero
Membrane Cholesterol Content Modulates ClC-2 Gating and Sensitivity to Oxidative Stress
J. Biol. Chem., January 26, 2007; 282(4): 2423 - 2432.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
Y. Li, W.-P. Yu, C.-W. Lin, and T.-Y. Chen
Oxidation and Reduction Control of the Inactivation Gating of Torpedo ClC-0 Chloride Channels
Biophys. J., June 1, 2005; 88(6): 3936 - 3945.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
G. E. Flynn and W. N. Zagotta
A Cysteine Scan of the Inner Vestibule of Cyclic Nucleotide-gated Channels Reveals Architecture and Rearrangement of the Pore
J. Gen. Physiol., May 27, 2003; 121(6): 563 - 583.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Mao, J. Wu, F. Chen, X. Wang, and C. Jiang
Inhibition of G-protein-coupled Inward Rectifying K+ Channels by Intracellular Acidosis
J. Biol. Chem., February 21, 2003; 278(9): 7091 - 7098.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Guo, G. J. Waldron, and R. Murrell-Lagnado
A Role for the Middle C Terminus of G-protein-activated Inward Rectifier Potassium Channels in Regulating Gating
J. Biol. Chem., December 6, 2002; 277(50): 48289 - 48294.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Cai, K. Zhang, and J. Lytton
A Novel Topology and Redox Regulation of the Rat Brain K+-dependent Na+/Ca2+ Exchanger, NCKX2
J. Biol. Chem., December 6, 2002; 277(50): 48923 - 48930.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/38/35564    most recent
M105189200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar